{
  "report_rows": [
    {
      "kpi": "2Q26 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.53B vs. cons $4.50B",
      "confidence": "HIGH"
    },
    {
      "kpi": "2Q26 adjusted EBIT",
      "prediction": "MISS",
      "answer": "pred ~$1.07B vs. cons $1.10B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 free cash flow",
      "prediction": "MISS",
      "answer": "pred ~-$0.15B vs. cons -$0.05B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EBIT",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.70B vs. cons $4.70B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H26 free cash flow",
      "prediction": "LOWER",
      "answer": "guide ~$1.15B vs. cons $1.25B (2H26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2H26 commercial-aftermarket organic growth",
      "prediction": "LOWER",
      "answer": "guide ~6% vs. cons 8% (2H26)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "~-$0.15B 2Q26 FCF versus -$0.05B consensus and ~$1.15B 2H26 FCF versus $1.25B consensus would make the unchanged ~$4.70B FY26 EBIT framework dependent on a more back-end-loaded recovery, pulling out-period cash-conversion and earnings estimates lower.",
  "day5_confidence": "MEDIUM"
}